ASCO 2024 annual conference highlights

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=P6qQcCwPIcQ

We review selected papers from the recent ASCO annual conference, followed by an audience Q A. Topics include: • Sequence your tumor before Pluvicto • More tough news if you've got the bad mutations... • With a BRCA mutatoin, get that PARP-I quickly! • Readily available solution to hot flashes if you're on abi • State-of-the-art personalized medicine and imaging • Cushioning the blows of ADT • A flop for metformin • Who should get treatment holidays? • Is alpha radiation the top dog? • Pressing AR's self-destruct • An angle on neuroendocrine • Predicting winners at immunotherapy • Who'll connect at BAT? • Doublet faceoff: ADT+chemo vs ADT+ARPI • In triplet trials, who really needed chemo? • Ranking PARP inhibitors for bone-marrow complications • When PSA and PSMA go different ways • Who's expressing PSMA? • Could CD46 be a better PSMA? • Niche for precision medicine: fused genes • AI keeps advancing • An OS oracle from UCSF • An OS oracle from ArteraAI • Taking on oligomets • Decipher without the sequencing • Slides available at https://drive.google.com/file/d/18Yr5...

#############################

New on site